Cargando…
Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078295/ https://www.ncbi.nlm.nih.gov/pubmed/33252377 http://dx.doi.org/10.1097/CM9.0000000000001235 |
_version_ | 1783685029944098816 |
---|---|
author | Teng, Fei Peng, Jin-Min Wang, Qian Tian, Xin-Lun Huo, Zhen Weng, Li |
author_facet | Teng, Fei Peng, Jin-Min Wang, Qian Tian, Xin-Lun Huo, Zhen Weng, Li |
author_sort | Teng, Fei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8078295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-80782952021-04-27 Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody Teng, Fei Peng, Jin-Min Wang, Qian Tian, Xin-Lun Huo, Zhen Weng, Li Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2021-04-20 2020-11-25 /pmc/articles/PMC8078295/ /pubmed/33252377 http://dx.doi.org/10.1097/CM9.0000000000001235 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Teng, Fei Peng, Jin-Min Wang, Qian Tian, Xin-Lun Huo, Zhen Weng, Li Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
title | Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
title_full | Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
title_fullStr | Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
title_full_unstemmed | Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
title_short | Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
title_sort | successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078295/ https://www.ncbi.nlm.nih.gov/pubmed/33252377 http://dx.doi.org/10.1097/CM9.0000000000001235 |
work_keys_str_mv | AT tengfei successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody AT pengjinmin successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody AT wangqian successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody AT tianxinlun successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody AT huozhen successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody AT wengli successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody |